CFO SpotlightsCareers of chief financial officers, from the filings. Records as of October 28, 2026
  1. CFO Spotlights
  2. Profiles
  3. Brent Sabatini, CPA, MBA

Profile

Brent Sabatini, CPA, MBA

Chief Financial Officer, Vir Biotechnology, Inc.

Former. First published here October 28, 2026; built from records as of October 28, 2026.

Vir Biotechnology, Inc. named Aziz Sawaf, MBEE, MBA, CFA to succeed Brent Sabatini, CPA, MBA, effective October 5, 2026.1

Seats

The seat in the record

CompanyTitle as filedStandingFilings
Vir Biotechnology, Inc. (VIR)
Biological Products, (No Diagnostic Substances)
Not statedFormer1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

  1. October 5, 2026effective

    Vir Biotechnology, Inc. named Aziz Sawaf, MBEE, MBA, CFA to succeed Brent Sabatini, CPA, MBA, effective October 5, 2026. Profile of Aziz Sawaf, MBEE, MBA, CFA.

    Aziz Sawaf, MBEE, MBA, CFA has been appointed as Executive Vice President and Chief Financial Officer and “principal financial officer” of the Company, effective as of October 5, 2026 (the Effective Date).

    [1] Filing by Vir Biotechnology, Inc., filed with the SEC on October 1, 2026. Read the filing. The record at CFO Tribune.

Sources

Sources

  1. Current report filed with the SEC, Vir Biotechnology, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed October 1, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Brent Sabatini, CPA, MBA wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.